missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human KDR (VEGFR2), His Tag Recombinant Protein
Click to view available options
Cantidad:
100 μg
10 μg
Tamaño de la unidad:
10 microgramos
100 microgramos
Descripción
For maximum recovery please spin prior to use. Unless noted below, aliquots of the 5 μg, 10 μg and 20 μg sizes of kinase are not recommended as materials can be used in original packaging until exhausted. For larger sizes, the number of freeze/thaws may be reduced by preparing aliquots, aliquots below 20 μL are not recommended. Please never store a kinase diluted. If properly stored at -80C, this product is guaranteed for 6 months from date of purchase. Protein Form: Cytoplasmic.
KDR (FLK1, VEGFR2) is a type III receptor tyrosine kinase. It binds vascular endothelial growth factor with high affinity in vitro, and is expressed early in development by endothelial cell precursors. FLK1 (VEGF Receptor 2) encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc. Mutations of FLK1 (VEGF Receptor 2) are implicated in infantile capillary hemangiomas.
Especificaciones
Especificaciones
| Número de acceso | P35968 |
| Concentración | See Label |
| Para utilizar con (aplicación) | Kinase Assay |
| Formulación | 50mM tris with 2mM DTT, 0.25mM EDTA, 50% glycerol, 150mM NaCl, 0.01% Triton X-100 and no preservative; pH 7.5 |
| ID de gen (Entrez) | 3791 |
| Peso molecular | 68.4 kDa |
| Nombre | Human KDR (VEGFR2), His Tag |
| Intervalo de pH | 7.5 |
| Método de purificación | Purified |
| Cantidad | 10 μg |
| Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido